News & Articles

Explore whether regenerative spine care may help your chronic back pain. Learn about biologic disc repair candidacy, what the fibrin procedure involves, and how it compares to surgery and other non-surgical options.

For patients weighing disc treatment options, this guide examines the risks of spinal fusion, the role of intra-annular fibrin injection, and the clinical situations where non-surgical biologic disc repair may be the smarter path forward.

For patients with chronic disc-related back pain, spinal fusion is not always the only option. This guide examines non-surgical pathways — including biologic disc repair — that may help many patients avoid fusion, with candidacy evaluated individually and outcomes that vary by case.

Compare biologic disc repair using intra-annular fibrin injection with traditional spine surgery. Learn how each approach addresses chronic discogenic pain, the differences in invasiveness and recovery, and how candidacy is determined on an individual basis.

Chronic lumbar pain lasting three months or more affects a significant portion of adults, and many find that conservative care or spinal fusion falls short. Regenerative approaches such as intra-annular fibrin injection may help address disc-level damage at its source — though candidacy and outcomes vary by case.

Intra-annular fibrin injection targets annular tears — a structural root cause of chronic discogenic back pain — through a minimally invasive outpatient procedure. For patients who meet candidacy criteria and have not found lasting relief through conservative care, this biologic disc repair approach may offer a non-surgical path to pain reduction and disc healing.

For many patients diagnosed with spinal instability, spinal fusion is not the only path forward. Non-surgical approaches — including biologic disc repair and targeted regenerative treatments — may help reduce pain and improve stability in appropriate candidates. Outcomes vary, and individual evaluation determines the right fit.